Comparison of the effect of aminophylline and low PEEP vs. high PEEP on EGF concentration in critically ill patients with ALI/ARDS

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 2, 2005, Pages 139-144

  Salari, P ^a   Mojtahedzadeh, M ^a   Najafi, A ^b   Sadraie, S ^a   Bahaadini, K ^a   Moharreri, M ^b   Hadavand, N ^a   Abdollahi, Mohammad ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Aminophylline; APACHE II score; Epidermal growth factor

Indexed keywords

AMINOPHYLLINE; EPIDERMAL GROWTH FACTOR;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICAL ILLNESS; ENDOTRACHEAL INTUBATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL;

AMINOPHYLLINE; APACHE; CRITICAL ILLNESS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OXYGEN; PARTIAL PRESSURE; PATIENT SELECTION; POSITIVE-PRESSURE RESPIRATION; RESPIRATORY DISTRESS SYNDROME, ADULT; TIME FACTORS;

EID: 20344370363     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00621.x     Document Type: Article

References (49)

1. Bernard G, Artigas A, Brigham KL et al. (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine, 149, 818-824.
2. Donnelly SC, Haslett C, Dransfield I et al. (1994) Role of selectins in development of adult respiratory distress syndrome. Lancet, 344, 215-219.
3. Charafeddine L, D'Angio CT, Richards JL et al. (1999) Hyperoxia increases keratinocyte growth factor mRNA expression in neonatal rabbit lung. American Journal of Physiology, 276, L105-L113.
4. Amishima M, Munakata M, Nasuhara Y, Sato A, Takahashi T, Hommay Y, Kawakami Y (1998) Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. American Journal of Respiratory and Critical Care Medicine, 157, 1907-1912.
5. Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, Holgate ST, Davies DE (2000) Involvement of epidermal growth factor receptor in epithelial repair in asthma. The FASEB Journal, 14, 1362-1374.
6. Kitadai Y, Haruma K, Sumii K et al. (1998) Expression of IL-8 correlates with vascularity in human gastric carcinomas. American Journal of Pathology, 152, 93-100.
7. Mawatari M, Kohno K, Mizoguchi H et al. (1989) Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors and the production of tissue inhibitor of metalloproteinase and IL-6 in human microvascular endothelial cells. Journal of Immunology, 143, 1619-1627.
8. Imai Y, Kawano T, Miyasaka K, Takasa M, Imai T, Okuyama K (1994) Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. American Journal of Respiratory and Critical Care Medicine, 150, 1550-1554.
9. Takata M, Abe J, Tanaka H, Kitano Y, Doi S, Kohsaka T, Miyasaka K (1997) Intra-alveolar expression of tumor necrosis factor ágene during conventional and high frequency ventilation. American Journal of Respiratory and Critical Care Medicine, 156, 272-279.
10. Decramer M, Deschepper K, Jiang TX, Derom E (1991) Effects of aminophylline on respiratory muscle interaction. The American Review of Respiratory Disease, 144, 797-802.
11. Barnes PJ, Pauwels RA (1994) Theophylline in asthma: time for reappraisal? The European Respiratory Journal, 7, 579-591.
12. Kraft M, Torvik JA, Trudeau JB, Wenzel SE, Martin RJ (1996) Theophylline: potential anti-inflammatory effects in nocturnal asthma. The Journal of Allergy and Clinical Immunology, 97, 1242-1246.
13. Canonico AE, Brigham KL (1997) The lung: scientific foundations. Philadelphia, PA: Lippincot Raven, 2476-2477.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Critical Care Medicine, 13, 818-829.
15. Tajerzadeh H, Sadray S (1999) High performance liquid chromatographic determination of theophylline in human serum. Medical Journal of Islamic Republic Iran, 13, 191-194.
16. Murray JF, Matthay MA, Luce JM, Flick MR (1988) An expanded definition of the adult respiratory distress syndrome. The American Review of Respiratory Disease, 138, 720-723.
17. Montgomery AB, Stager MA, Carrico CJ, Hudson LD (1985) Causes of mortality in patients with the adult respiratory distress syndrome. The American Review of Respiratory Disease, 132, 485-489.
18. Ferring M, Vincent JL (1997) Is outcome from ARDS related to the severity of respiratory failure? The European Respiratory Journal, 10, 1297-1300.
19. Donnelly SC, Strietert RM, Kunkel SL et al. (1994) Chemotactic cytokines in the established adult respiratory distress syndrome and at-risk patients. Chest, 105, 98S-99S.
20. Tutor JD, Mason CM, Dobard E, Beckerman RC, Summer WR, Nelson S (1994) Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. American Journal of Respiratory and Critical Care Medicine, 149, 1107-1111.
21. Nicod LP (1993) Cytokines. 1. Overview. Thorax, 48, 660-667.
22. Martinet Y, Menard O, Vaillant P, Vignaud JM, Martinet N (1996) Cytokines in lung fibrosis. Archives of Toxicology Supplement, 18, 127-139.
23. Cohen MC, Cohen S (1996) Cytokines function: a study in biologic diversity. American Journal of Clinical Pathology, 105, 589-598.
24. Luster AD (1998) Chemokines-chemotactic cytokines that mediate inflammation. New England Journal of Medicine, 338, 436-445.
25. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR (1996) Proinflammatory activity in bronchalveolar lavage fluid from patients with ARDS a prominent role for interleukin-1. American Journal of Respiratory and Critical Care Medicine, 153, 1850-1856.
26. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K (1995) Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest, 107, 1062-1073.
27. Chollet-Martin S, Jourdain B, Gibert C, Elbim C, Chastre J, Gougerot-Pocidalo MA (1996) Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. American Journal of Respiratory and Critical Care Medicine, 153, 594-601.
28. St John RC, Mizer LA, Kindt GC, Weisbrode SE, Dorinsky PM (1993) Acid aspiration-induced acute lung injury causes leukocyte-dependent systemic organ injury. Journal of Applied Physiology, 74, 1994-2003.
29. Gullo A, Berlot G, Viviani M (1996) The role of adult respiratory distress syndrome in the multiple organ dysfunction syndrome. Acta Anaesthesiologica Scandinavica Supplementum, 109, 70-73.
30. Kelley J (1990) Cytokines of the lung. The American Review of Respiratory Disease, 141, 765-788.
31. Davies DE, Polosa R, Puddicombe SM, Richter A, Holgate ST (1999) The epidermal growth factor receptor and its ligand family: their potential role in repair and remodeling in asthma. Allergy, 58, 771-783.
32. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS (1997) Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. The Journal of Clinical Investigation, 99, 944-952.
33. Chiumello D, Pristine G, Baba A, Slutsky AS (1998) Mechanical ventilation affects local and systemic cytokines in an animal model of ARDS. American Journal of Respiratory and Critical Care Medicine, 157, A45-A51.
34. Suter PM (2002) MV causes lung inflammation and systemic immune depression. A balance of fire and ice. Intensive Care Medicine, 28, 383-385.
35. Amato MB, Barbas CS, Medeiros DM et al. (1998) Effect of protective-ventilation strategy on mortality in the acute respiratory distress syndrome. New England Journal of Medicine, 338, 347-354.
36. Slutsky AS, Tremblay LN (1998) Multiple system organ failure. Is mechanical ventilation a contributing factor? American Journal of Respiratory and Critical Care Medicine, 157, 1721-1725.
37. Wrigge H, Zinserling J, Stuber F et al. (2000) Effects of mechanical ventilation on release of cytokines into systemic circulation in patients with normal pulmonary function. Anesthesiology, 93, 1413-1417.
38. Culpitt SV, de Matos C, Russell RE, Donnelly LE, Rogers DF, Barnes PJ (2002) Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in COPD. American Journal of Respiratory and Critical Care Medicine, 165, 1371-1376.
39. Barnes PJ (2003) Theophylline: new perspectives for an old drug. American Journal of Respiratory and Critical Care Medicine, 167, 813-818.
40. Bergstrand H (1980) Phosphodiesterase inhibition and theophylline. European Journal of Respiratory Disease Supply, 109, 37-44.
41. Fredholm BB, Persson CG (1982) Xanthine derivatives as adenosine antagonists. European Journal of Pharmacology, 81, 673-676.
42. Ezeamuzie CI (2001) Involvement of A (3) receptors in the potentiation by adenosine of the inhibitory effect of theophylline on human eosinophil degranulation: possible novel mechanism of the anti-inflammatory action of theophylline. Biochemical Pharmacology, 61, 1551-1559.
43. Yasui K, Hu B, Nakazawa T, Agematsu K, Komiyama A (1997) Theophylline accelerates human granulocytes apoptosis not via phosphodiesterase inhibition. The Journal of Clinical Investigation, 100, 1677-1684.
44. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT (1991) Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5′-cyclic monophosphate. Journal of Immunology, 146, 2712-2718.
45. Hatzelmann A, Tenor H, Schudt C (1995) Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. British Journal of Pharmacology, 114, 821-831.
46. Abdollahi M, Simaiee B (2003) Stimulation by theophylline and sildenafil of rat submandibular secretion of protein, epidermal growth factor and flow rate. Pharmacology Research, 48, 445-449.
47. Ranieri VM, Suter PM, Tortorella C et al. (1999) Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA, 282, 54-61.
48. Carden DL, Alexander S, George RB (1998) The pathophysiology of the acute respiratory distress syndrome. Pathophysiology, 5, 1-13.
49. Chiumello D, Pristine G, Slutsky AS (1999) Mechanical ventilation affects local and systemic cytokines in animal models of acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine, 160, 109-116.